Research Use Only Disclaimer
Effective: September 1, 2026
FDA and pharmacy status
Products offered by BlueLine Peptides have not been evaluated or approved by the U.S. Food and Drug Administration for human or veterinary use. They are not intended to diagnose, treat, cure, or prevent any disease or condition. BlueLine is not a section 503A compounding pharmacy and is not a section 503B outsourcing facility.
No medical or use instructions
Nothing on this website, in customer communications, on a label, or in an analytical report is medical advice. BlueLine does not provide dosing, preparation, mixing, reconstitution, injection, administration, treatment, or clinical-use guidance. Product names, catalog organization, scientific references, and analytical documents do not represent a claim of safety, efficacy, or suitability for any purpose.
Purchaser responsibility
Purchase is limited to persons at least 21 years old acquiring materials solely for lawful laboratory or in-vitro research. The purchaser is responsible for qualified personnel, appropriate facilities, risk assessment, protective equipment, storage, handling, disposal, recordkeeping, and compliance with federal, state, local, and other applicable laws. BlueLine may request information, limit quantities, or refuse or cancel an order for compliance or safety reasons.
Lot documentation
Any certificate of analysis or analytical report applies only to the exact lot identified. A report is not evidence of FDA approval and does not establish sterility, clinical safety, or suitability unless the document expressly reports that specific test for that specific lot.
By purchasing, you certify that you understand and will follow these restrictions. These statements supplement the Terms & Conditions.
← Return to BlueLine